This Week in Washington: House Ways and Means Committee marks up healthcare bills related to new technologies and coverage for weight loss drugs; CMS releases CY2025 Home Health and End-Stage Renal Disease PPS proposed rules; Supreme Court overturns Chevron Doctrine and dismisses Idaho EMTALA case.
House of Representatives
The House of Representatives is in district work
This Week in Washington: House appropriators release FY2025 topline appropriations levels; Senate Finance Committee releases white paper on Medicare physician payment reforms; House Energy and Commerce Committee Subcommittee on Health marks up 21 bills.
House
House Appropriators Release FY2025 Topline Funding Amounts
On May 16, House appropriators released topline funding amounts for the fiscal year (FY)
This Week in Washington: House Ways and Means Committee marks up telehealth legislation; CMS extends state Medicaid unwinding flexibilities; Senate HELP Committee ranking member releases white paper outlining possible NIH reforms.
House
House Ways and Means Committee Marks Up Telehealth Legislation
On May 8, the House Ways and Means Committee marked up and reported out of
This Week in Washington: House Energy and Commerce Committee Subcommittee on Health holds hearing on a range of legislation concerning public health programs, patient wellbeing and caregiver support; HHS and FTC request information on group purchasing organization and drug wholesaler business practices.
House
House Energy and Commerce Committee Subcommittee On Health Holds Hearing on Multiple
This Week in Washington: Senate Finance Committee holds hearing on AI use in healthcare; CMS makes corrections to 2024 Hospital Outpatient Prospective Payment Rates; House passes ban on QALYs.
House
House Budget Committee Favorably Reports Dr. Michael C. Burgess Preventive Health Savings Act
On Feb. 6, the House Budget Committee marked up and reported out
This Week in Washington: CMS releases 2025 MA and Part D proposed payment Advance Notice; CMS sends first fair drug price offers to Drug Price Negotiation Program companies; SAMHSA releases final rule making virtual prescribing of buprenorphine permanent; Biogen pulls Aduhelm from market; Supreme Court to hear mifepristone case oral arguments on March 26.
Congress